GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $503,000 | +65.5% | 13,159 | +102.5% | 0.02% | +53.3% |
| Q2 2021 | $304,000 | -99.8% | 6,497 | +64.6% | 0.02% | +25.0% |
| Q1 2021 | $140,885,000 | +66043.2% | 3,947 | -31.9% | 0.01% | -70.7% |
| Q4 2020 | $213,000 | -32.8% | 5,800 | -25.3% | 0.04% | -58.6% |
| Q3 2020 | $317,000 | 0.0% | 7,769 | 0.0% | 0.10% | +8.8% |
| Q2 2020 | $317,000 | +3.9% | 7,769 | -3.8% | 0.09% | +85.7% |
| Q1 2020 | $305,000 | -11.8% | 8,073 | +9.6% | 0.05% | -32.9% |
| Q4 2019 | $346,000 | +4.2% | 7,365 | -5.1% | 0.07% | +9.0% |
| Q3 2019 | $332,000 | +36.1% | 7,759 | +27.5% | 0.07% | -42.2% |
| Q2 2019 | $244,000 | -6.9% | 6,085 | -2.8% | 0.12% | +141.7% |
| Q1 2019 | $262,000 | -35.9% | 6,259 | -41.5% | 0.05% | -45.5% |
| Q4 2018 | $409,000 | – | 10,704 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |